Redefining the Role of Etoposide in First-Line Treatment of Peripheral T-Cell Lymphoma

Blood advances - United States
doi 10.1182/bloodadvances.2017010819
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

American Society of Hematology

Related search

Redefining the Role of Etoposide in Peripheral T-Cell Lymphoma Treatment

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Effects of First-Line Chemotherapy on Natural Killer Cells in Adult T-Cell Leukemia–lymphoma and Peripheral T-Cell Lymphoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

Chidamide in the Treatment of Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Recent Advances in the Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2018English

Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Treatment of Metastatic Germ Cell Tumors With Etoposide and Cisplatin as First Line Chemotherapy

Japanese Journal of Urology
Urology
2002English

Autologous Stem Cell Transplantation as Part of First-Line Therapy in Patients With Peripheral T-Cell Lymphoma: A Multicenter Geltamo/Fil Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy